{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:18:26Z","timestamp":1793089106132,"version":"4.5.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"NIHR Birmingham Biomedical Research Centre"},{"name":"NHS"},{"name":"National Institute for Health Research or the Department of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sj\u00f6gren\u2019s syndrome (SjS) accompanied by other systemic autoimmune rheumatic connective tissue diseases has historically been termed \u2018secondary\u2019 in contrast to \u2018primary\u2019 SjS as a standalone entity. However, it is a matter of a long-standing debate whether the prefixes \u2018primary\u2019 and \u2018secondary\u2019, including a temporal component, are obsolete in the terminology of SjS. We review the history and the pathophysiological, chronological, genetic, histological and clinical data underlying the concept of \u2018secondary\u2019 SjS. There are important unintended consequences of the nomenclature; notably \u2018secondary\u2019 SjS has been much less researched and is often excluded from clinical trials. We argue for further research, a change in terminology and more stringent classification. Further we highlight possible opportunities for trials in SjS and other systemic autoimmune diseases that might contribute to an advance in care for all patients with SjS.<\/jats:p>","DOI":"10.1093\/rheumatology\/keaa009","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T12:10:25Z","timestamp":1578485425000},"page":"1218-1225","source":"Crossref","is-referenced-by-count":59,"title":["Equal rights in autoimmunity: is Sj\u00f6gren\u2019s syndrome ever \u2018secondary\u2019?"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8172-1285","authenticated-orcid":false,"given":"Florian","family":"Kollert","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Immunology, and Allergology, Inselspital, University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-549X","authenticated-orcid":false,"given":"Benjamin A","family":"Fisher","sequence":"first","affiliation":[{"name":"Rheumatology Research Group, Institute\u00a0of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham"},{"name":"National Institute for Health Research (NIHR), Birmingham Biomedical Research Centre and Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"2020052301003369800_keaa009-B1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaut.2012.05.008","article-title":"Sj\u00f6gren\u2019s syndrome at the crossroad of polyautoimmunity","volume":"39","author":"Amador-Patarroyo","year":"2012","journal-title":"J Autoimmun"},{"key":"2020052301003369800_keaa009-B2","doi-asserted-by":"crossref","first-page":"e000443","DOI":"10.1136\/rmdopen-2017-000443","article-title":"Patient burden of Sjogren's: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity","volume":"3","author":"Hammitt","year":"2017","journal-title":"RMD Open"},{"key":"2020052301003369800_keaa009-B3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00005792-199211000-00005","article-title":"Sjogren's syndrome. A clinical, pathological, and serological study of sixty-two cases. 1965","volume":"71","author":"Bloch","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"2020052301003369800_keaa009-B4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2020052301003369800_keaa009-B5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2020052301003369800_keaa009-B6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2020052301003369800_keaa009-B7","first-page":"730","article-title":"Primary and secondary Sjogren's syndrome","volume":"2","year":"1984","journal-title":"Lancet"},{"key":"2020052301003369800_keaa009-B8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7326\/0003-4819-92-2-212","article-title":"Sjogren's syndrome (Sicca syndrome): current issues","volume":"92","author":"Moutsopoulos","year":"1980","journal-title":"Ann Intern Med"},{"key":"2020052301003369800_keaa009-B9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.7326\/0003-4819-87-6-703","article-title":"Sjogren-type syndrome after allogeneic bone-marrow transplantation","volume":"87","author":"Gratwohl","year":"1977","journal-title":"Ann Intern Med"},{"key":"2020052301003369800_keaa009-B10","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbmt.2010.03.023","article-title":"Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation","volume":"16","author":"Imanguli","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020052301003369800_keaa009-B11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0002-9343(79)91110-0","article-title":"Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis","volume":"66","author":"Moutsopoulos","year":"1979","journal-title":"Am J Med"},{"key":"2020052301003369800_keaa009-B12","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/rheumatology\/kes374","article-title":"Characteristics of Sjogren's syndrome in rheumatoid arthritis","volume":"52","author":"He","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2020052301003369800_keaa009-B13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.20093","article-title":"Sjogren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren's syndrome","volume":"50","author":"Manoussakis","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2020052301003369800_keaa009-B14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM197910043011405","article-title":"Genetic differences between primary and secondary sicca syndrome","volume":"301","author":"Moutsopoulos","year":"1979","journal-title":"N Engl J Med"},{"key":"2020052301003369800_keaa009-B15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/03009748109095284","article-title":"HLA-D antigen frequencies in Sjogren's syndrome. Differences between the primary and secondary form","volume":"10","author":"Manthorpe","year":"1981","journal-title":"Scand J Rheumatol"},{"key":"2020052301003369800_keaa009-B16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.rdc.2008.08.003","article-title":"Genes and Sjogren's syndrome","volume":"34","author":"Cobb","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"2020052301003369800_keaa009-B17","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.39560","article-title":"X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47, XXX in systemic lupus erythematosus and Sjogren's syndrome","volume":"68","author":"Liu","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2020052301003369800_keaa009-B18","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.40207","article-title":"Rare X chromosome abnormalities in systemic lupus erythematosus and Sjogren's syndrome","volume":"69","author":"Sharma","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2020052301003369800_keaa009-B19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/gene.2008.1","article-title":"Variant form of STAT4 is associated with primary Sjogren's syndrome","volume":"9","author":"Korman","year":"2008","journal-title":"Genes Immun"},{"key":"2020052301003369800_keaa009-B20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/gene.2008.94","article-title":"Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome","volume":"10","author":"Nordmark","year":"2009","journal-title":"Genes Immun"},{"key":"2020052301003369800_keaa009-B21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jbspin.2016.11.012","article-title":"The autoimmune tautology. A summary of evidence","volume":"84","author":"Anaya","year":"2017","journal-title":"Joint Bone Spine"},{"key":"2020052301003369800_keaa009-B22","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.3933","article-title":"Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases","volume":"21","author":"Li","year":"2015","journal-title":"Nat Med"},{"key":"2020052301003369800_keaa009-B23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.10137","article-title":"Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjogren's syndrome","volume":"46","author":"Aractingi","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2020052301003369800_keaa009-B24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3899\/jrheum.090866","article-title":"Similarities and differences between primary and secondary Sjogren's syndrome","volume":"37","author":"Hern\u00e1ndez-Molina","year":"2010","journal-title":"J Rheumatol"},{"key":"2020052301003369800_keaa009-B25","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/art.21922","article-title":"Systemic sclerosis-associated Sjogren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients","volume":"54","author":"Avouac","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2020052301003369800_keaa009-B26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/kel252","article-title":"Sjogren's syndrome is associated with and not secondary to systemic sclerosis","volume":"46","author":"Salliot","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2020052301003369800_keaa009-B27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/03009748609092600","article-title":"Hand radiographic changes in patients with primary and secondary Sjogren's syndrome","volume":"15","author":"Tsampoulas","year":"1986","journal-title":"Scand J Rheumatol"},{"key":"2020052301003369800_keaa009-B28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/rheumatology\/keu400","article-title":"Clinical characteristics of RA patients with secondary SS and association with joint damage","volume":"54","author":"Brown","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2020052301003369800_keaa009-B29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/acr.23107","article-title":"Relationship between neuromyelitis optica spectrum disorder and Sjogren's syndrome: central nervous system extraglandular disease or unrelated, co-occurring autoimmunity?","volume":"69","author":"Birnbaum","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2020052301003369800_keaa009-B30","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2007.077883","article-title":"Is Sjogren myelopathy Devic disease?","volume":"67","author":"Sofat","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2020052301003369800_keaa009-B31","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2012-202863","article-title":"Health-related utility values of patients with primary Sjogren's syndrome and its predictors","volume":"73","author":"Lendrem","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2020052301003369800_keaa009-B32","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/key370","article-title":"Health-related quality of life and costs in Sjogren's syndrome","author":"Miyamoto","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2020052301003369800_keaa009-B33","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/art.40425","article-title":"Efficacy of epratuzumab, an anti-CD22 monoclonal IgG antibody, in systemic lupus erythematosus patients with associated Sjogren's syndrome: post-hoc analyses from the EMBODY trials","volume":"70","author":"Gottenberg","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2020052301003369800_keaa009-B34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s002960050023","article-title":"Anti-Ro (SSA) antibodies in rheumatoid arthritis patients with gold-induced side effects","volume":"17","author":"Tishler","year":"1997","journal-title":"Rheumatol Int"},{"key":"2020052301003369800_keaa009-B35","first-page":"1040","article-title":"Anti-Ro (SSA) antibodies in patients with rheumatoid arthritis\u2013a possible marker for gold induced side effects","volume":"21","author":"Tishler","year":"1994","journal-title":"J Rheumatol"},{"key":"2020052301003369800_keaa009-B36","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3899\/jrheum.101295","article-title":"Anti-Ro\/SSA antibodies are an independent factor associated with an insufficient response to tumor necrosis factor inhibitors in patients with rheumatoid arthritis","volume":"38","author":"Matsudaira","year":"2011","journal-title":"J Rheumatol"},{"key":"2020052301003369800_keaa009-B37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":"Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS)","volume":"50","author":"Mariette","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2020052301003369800_keaa009-B38","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.20299","article-title":"Etanercept in Sjogren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial","volume":"50","author":"Sankar","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2020052301003369800_keaa009-B39","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/art.23062","article-title":"Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept","volume":"56","author":"Mavragani","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2020052301003369800_keaa009-B40","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4049\/jimmunol.172.2.812","article-title":"TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma","volume":"172","author":"Batten","year":"2004","journal-title":"J Immunol"},{"key":"2020052301003369800_keaa009-B41","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020052301003369800_keaa009-B42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/14397595.2014.951144","article-title":"Efficacy and safety of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sj\u00f6gren's syndrome Endocrinopathy (ROSE) trial-an open-label, one-year, prospective study-Interim analysis of 32 patients for 24 weeks","volume":"25","author":"Tsuboi","year":"2015","journal-title":"Mod Rheumatol"},{"key":"2020052301003369800_keaa009-B43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/rheumatology\/kez242","article-title":"Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjogren's syndrome in the JOQUER randomized trial","volume":"59","author":"Bodewes","year":"2020","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/6\/1218\/33285539\/keaa009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/6\/1218\/33285539\/keaa009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T21:19:56Z","timestamp":1695590396000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/6\/1218\/5727909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,5]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,2,5]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa009","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,2,5]]}}}